metastatic breast cancer

Showing NaN - NaN of 54

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dose Escalation, Safety, Preliminary Efficacy Trial in Worldwide (LDE225, BKM120)

Completed
  • Dose Escalation
  • +11 more
  • Los Angeles, California
  • +22 more
Dec 16, 2020

Metastatic Breast Cancer Trial in Worldwide (OPT-822/OPT-821(30 µg/100 µg), Phosphate Buffer Saline (PBS), Cyclophosphamide)

Completed
  • Metastatic Breast Cancer
  • OPT-822/OPT-821(30 μg/100 μg)
  • +2 more
  • Birmingham, Alabama
  • +42 more
Sep 14, 2020

Metastatic Breast Cancer Trial in Houston (Exemestane, Sutent)

Terminated
  • Metastatic Breast Cancer
  • Houston, Texas
    Baylor College of Medicine, Lester and Sue Smith Breast Center
Jul 9, 2020

Breast Cancer, Metastatic Breast Cancer, MBC Trial in United States (Lucitanib)

Terminated
  • Breast Cancer
  • +7 more
  • Sedona, Arizona
  • +32 more
Jun 20, 2020

Metastatic Breast Cancer Trial in Poland, United States (Docetaxel, Placebo, Indoximod)

Completed
  • Metastatic Breast Cancer
  • Gainesville, Florida
  • +39 more
May 26, 2020

Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

Completed
  • Hematological Neoplasms
  • +19 more
  • Scottsdale, Arizona
  • +9 more
May 11, 2020

Metastatic Breast Cancer Trial in Worldwide (Abemaciclib)

Completed
  • Metastatic Breast Cancer
  • Sedona, Arizona
  • +35 more
Jan 10, 2020

Metastatic Breast Cancer Trial in Worldwide (Pertuzumab, Placebo, Trastuzumab)

Completed
  • Metastatic Breast Cancer
  • Scottsdale, Arizona
  • +321 more
Dec 12, 2019

Metastatic Breast Cancer Trial in Houston (ABI-008 (nab-docetaxel))

Terminated
  • Metastatic Breast Cancer
  • ABI-008 (nab-docetaxel)
  • Houston, Texas
    University of Texas M.D. Anderson Cancer Center
Nov 13, 2019

Metastatic Breast Cancer Trial in Worldwide (Abemaciclib, Nonsteroidal Aromatase Inhibitor (NSAI))

Withdrawn
  • Metastatic Breast Cancer
  • Daphne, Alabama
  • +118 more
Sep 4, 2019

Metastatic Breast Cancer Trial in Houston (T-DM1, Lapatinib, Abraxane)

Completed
  • Metastatic Breast Cancer
  • Houston, Texas
    Houston Methodist Hospital
Apr 12, 2019

Metastatic Breast Cancer Trial in Worldwide (Fulvestrant, BKM120, BKM120 matching )

Terminated
  • Metastatic Breast Cancer
  • Mobile, Alabama
  • +196 more
Jan 9, 2019

Breast Cancer, Triple Negative Breast Cancer, Stage IV Breast Cancer Trial in United States (Abraxane alone, Abraxane +

Completed
  • Breast Cancer
  • +3 more
  • Abraxane alone
  • Abraxane + Tigatuzumab
  • Birmingham, Alabama
  • +9 more
Oct 24, 2017

HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (everolimus, Placebo,

Completed
  • HER2/Neu Over-expressing Locally Advanced Breast Cancer
  • Metastatic Breast Cancer
  • Tucson, Arizona
  • +160 more
Feb 20, 2017

Circulating Tumor Cells From Metastatic Breast Cancer Using

Completed
  • Metastatic Breast Cancer
  • Blood collection
  • Phoenix, Arizona
  • +19 more
Mar 7, 2017

Metastatic Breast Cancer Trial in United States (Ixabepilone, Carboplatin)

Completed
  • Metastatic Breast Cancer
  • Phoenix, Arizona
  • +58 more
Oct 14, 2016

Metastatic Breast Cancer Trial in United States (Pegylated liposomal doxorubicin, Carboplatin, trastuzumab)

Completed
  • Metastatic Breast Cancer
  • Pegylated liposomal doxorubicin
  • +2 more
  • Birmingham, Alabama
  • +56 more
Sep 15, 2016

Advanced Nonhematological Malignancies, NSCLC, Small Cell Lung Cancer Trial in Houston, Salt Lake City (MLN8237 (Alisertib))

Completed
  • Advanced Nonhematological Malignancies
  • +5 more
  • MLN8237 (Alisertib)
  • Houston, Texas
  • +1 more
Jul 1, 2016

Metastatic Breast Cancer Trial in United States (Dasatinib, Letrozole)

Completed
  • Metastatic Breast Cancer
  • Sedona, Arizona
  • +26 more
May 10, 2016

Metastatic Breast Cancer Trial in United States (Ixabepilone)

Completed
  • Metastatic Breast Cancer
  • Birmingham, Alabama
  • +56 more
Feb 9, 2016

Metastatic Breast Cancer, Tumors, Breast Trial in United States (Investigational Cancer Drug)

Completed
  • Metastatic Breast Cancer
  • Neoplasms, Breast
  • Investigational Cancer Drug
  • Chula Vista, California
  • +29 more
Apr 14, 2015

Locally Advanced Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (Fulvestrant, Exemestane)

Completed
  • Locally Advanced Breast Cancer
  • Metastatic Breast Cancer
  • Birmingham, Alabama
  • +116 more
Feb 23, 2015

Triple Negative Breast Cancer Biomarker Study

Completed
  • Metastatic Breast Cancer
  • Triple Negative Breast Cancer
    • Denver, Colorado
    • +17 more
    Jul 19, 2013

    Metastatic Breast Cancer Trial in United States (Trastuzumab emtansine [Kadcyla])

    Completed
    • Metastatic Breast Cancer
    • Trastuzumab emtansine [Kadcyla]
    • Little Rock, Arkansas
    • +39 more
    Feb 22, 2013